Optimi Health ships psilocybin to UK for phase 2 clinical trial
Tweet Send to a Friend
Optimi Health Corp. (NASDAQ: OPTH) completed its first export of psilocybin to the United Kingdom to support a planned Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


